AiCuris Launches Phase 1 Trial for BK Virus in Kidney Transplants
31 Oct 2024 //
BUSINESSWIRE
AiCuris Appoints Cynthia Wat as Chief Medical Officer
30 Jul 2024 //
BUSINESSWIRE
AiCuris Achieves Milestones In Anti-viral Solutions For At-Risk Patients
17 Jul 2024 //
BUSINESSWIRE
AiCuris Announces Shift to Focus Development of Anti-infectives
06 Jul 2023 //
ACCESSWIRE
AiCuris Announces Appointment of Larry Edwards as Chief Executive Officer
04 Apr 2023 //
ACCESSWIRE
AiCuris and Hybridize sign licence agreement for BK virus therapy
10 Feb 2022 //
PHARMACEUTICAL-TECHNOLOGY
AiCuris Announces Expansion of its Collaboration with Lysando
22 Oct 2021 //
BIOSPACE
AiCuris Opens 2nd Round of AiCubator Corporate Innovation Accelerator Initiative
07 Oct 2021 //
BIOSPACE